Does age influence the behaviour of localized prostate cancer?

scientific article published in May 2001

Does age influence the behaviour of localized prostate cancer? is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814

External links are
P356DOI10.1046/J.1464-410X.2001.02141.X
P8608Fatcat IDrelease_dres3p4i2ne5bdjnsrfvyc572i
P698PubMed publication ID11350402

P50authorPadraig WardeQ48044256
P2093author name stringC C Parker
M Gospodarowicz
P2860cites workPrimary treatment choices for men with clinically localized prostate carcinoma detected by screeningQ46977038
Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer.Q52418332
Results of conservative management of clinically localized prostate cancer.Q52884523
Clinical course of early onset prostate cancer with special reference to family history as a prognostic factor.Q52903987
Localized prostate cancer in elderly patients. Outcome after radiation therapy compared to matched younger patients.Q53536411
Results of radical prostatectomy in men with clinically localized prostate cancerQ34393990
Natural History and Prognosis of Prostate Carcinoma in Adolescents and Men under 35 Years of AgeQ36289915
Carcinoma of prostate in men less than fifty years old. Data from American College of Surgeons' National SurveyQ36652069
The National Cancer Data Base report on race, age, and region variations in prostate cancer treatmentQ36884863
Dilemmas in treating early prostate cancer: the evidence and a questionnaire survey of consultant urologists in the United KingdomQ38633306
Deferred treatment of localized prostate cancer in the elderly: the impact of the age and stage at the time of diagnosis on the treatment decisionQ39534056
Cancer of the prostate. Do younger men have a poorer survival rate?Q40226006
Prostate adenocarcinoma in men younger than 50 years. A retrospective review of 151 patients.Q40700601
The relationship between biochemical failure and time to nadir in patients treated with external beam therapy for T1-T3 prostate carcinomaQ40838811
A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinomaQ40907007
Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs systemQ41659782
Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patientsQ43201975
P433issue7
P304page(s)629-637
P577publication date2001-05-01
P1433published inBJU InternationalQ4835773
P1476titleDoes age influence the behaviour of localized prostate cancer?
P478volume87

Reverse relations

cites work (P2860)
Q46282060A 43-year-old African American man with low-risk prostate cancer
Q78688136Advanced age at diagnosis is an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma
Q46661409Analysis of impact of age and race on biochemical control after radiotherapy in different prostate cancer settings
Q81780919Analysis of influence of age on acute and chronic radiotherapy toxicity in treatment of prostate cancer
Q57566962Cancer de la prostate
Q87176751Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger
Q35123237Contemporary pathology of prostate cancer
Q44536250Controversial predictors of biochemical recurrence after radical prostatectomy: a study from a Latin American (Brazilian) institution
Q37375491Determinants of change in prostate-specific antigen over time and its association with recurrence after external beam radiation therapy for prostate cancer in five large cohorts
Q40586543Factors determining biochemical recurrence in low-risk prostate cancer patients who underwent radical prostatectomy
Q38873431High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer
Q36746831Impact of Age at Diagnosis on Outcomes in Men with Castrate-Resistant Prostate Cancer (CRPC).
Q38835014Is Age an Independent Factor for Prostate Cancer? A Paired Analysis
Q36361706Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trials
Q36103672Part 1: The burden of prostate cancer, its natural history, information on the outcome of screening and estimates of ad hoc screening with particular reference to England and Wales
Q28388487Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond
Q35108252Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future
Q39925854Survival and prognostic factors of patients with clinically localized prostate cancer
Q36034209The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer

Search more.